Option Care Health Appoints Robert Okunski as Vice President, Investor Relations
Rhea-AI Summary
Option Care Health (NASDAQ: OPCH) appointed Robert (Bob) Okunski as Vice President, Investor Relations, effective May 26, 2026. He will lead investor relations strategy, act as primary liaison with the investment community, and communicate business strategy, financial performance, capital allocation priorities and long-term growth opportunities.
Okunski previously led investor relations at Enhabit Home Health & Hospice and held senior roles at Velo3D, SunPower, Spansion and PeopleSoft. He holds an MBA from Moravian University and a BA from Colgate University.
AI-generated analysis. Not financial advice.
Positive
- None.
Negative
- None.
Key Figures
Market Reality Check
Peers on Argus
Peers show mixed moves: AMED -0.03%, CHE +2.31%, ACHC +0.82%, DVA +3.47%, SGRY -1.39%. With no momentum signals in peers, OPCH trading appears more stock-specific.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jun 01 | Impact ranking award | Positive | -2.0% | TIME/Statista named OPCH No. 15 among impactful global companies. |
| May 04 | Conference participation | Neutral | +0.8% | Announced participation and webcast at Bank of America Health Care Conference. |
| Apr 30 | Q1 2026 earnings | Negative | -24.3% | Q1 2026 results with adjusted EBITDA down 6.3% and updated guidance. |
| Apr 08 | Earnings date notice | Neutral | +1.1% | Set reporting date and call details for Q1 2026 results. |
| Feb 24 | FY 2025 earnings | Positive | -6.3% | Reported 13% revenue growth and 2026 guidance with higher EBITDA targets. |
Recent news often met with muted or negative reactions, even on fundamentally positive updates.
Over the past few months, Option Care Health has reported several milestones. Recognition by TIME as one of the World’s Most Impactful Companies 2026 and participation in a major Bank of America healthcare conference highlighted its franchise scale of over 8,000 team members and 5,000 clinicians. Earnings updates showed Q1 2026 net revenue of $1,350.7M with adjusted EBITDA of $104.8M, and full‑year 2025 net revenue of $5,649.5M with adjusted EBITDA of $471.3M. The current investor relations leadership appointment fits into this broader focus on visibility and communication.
Market Pulse Summary
This announcement centers on governance and communication, with Option Care Health appointing an experienced Vice President of Investor Relations effective May 26, 2026. The hire emphasizes engagement with investors and clear articulation of strategy, capital allocation, and long-term growth. In recent quarters the company reported net revenue of $1,350.7M for Q1 2026 and full‑year 2025 revenue of $5,649.5M, alongside detailed 2026 guidance. Investors may watch how enhanced outreach shapes perception of these existing financial targets.
AI-generated analysis. Not financial advice.
BANNOCKBURN, Ill., June 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced the appointment of Robert Okunski as Vice President, Investor Relations effective May 26, 2026.
In this role, Okunski will lead the Company’s investor relations strategy and serve as the primary liaison between Option Care Health and the investment community. He will be responsible for communicating the Company’s business strategy, financial performance, capital allocation priorities and long-term growth opportunities to investors, analysts and other key stakeholders.
“Bob brings more than two decades of investor relations leadership experience across healthcare, technology and energy industries,” said Meenal Sethna, Chief Financial Officer of Option Care Health. “His proven track record of building best-in-class investor relations programs, strengthening investor engagement and enhancing transparency, elevating corporate visibility, will be invaluable as we continue to execute our growth strategy and create long-term shareholder value.”
Okunski joins Option Care Health from Enhabit Home Health & Hospice, where he served as Vice President of Investor Relations. During his tenure, he led the company’s investor relations strategy, enhanced engagement with institutional investors and analysts, and increased the company’s visibility within the investment community.
Prior to Enhabit, Okunski held senior investor relations leadership positions at Velo3D Inc., SunPower Corporation, Spansion Inc. and PeopleSoft.
Okunski holds a Master of Business Administration from Moravian University and a Bachelor of Arts from Colgate University.
About Option Care Health
Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 8,000 team members including more than 5,000 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and team members. To learn more, please visit our website at optioncarehealth.com.
For Investor Inquiries:
| Bob Okunski |
| Vice President, Investor Relations |
| robert.okunski@optioncare.com |
